CME Group (NASDAQ:CME) PT Raised to $228.00 at Barclays

CME Group (NASDAQ:CME) had its price target upped by stock analysts at Barclays from $226.00 to $228.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage currently has an “equal weight” rating on the financial services provider’s stock. Barclays‘s price objective indicates a potential upside of 8.09% from the stock’s current price.

CME has been the topic of a number of other research reports. Argus raised their target price on shares of CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a research note on Wednesday, March 6th. JPMorgan Chase & Co. raised their target price on shares of CME Group from $198.00 to $206.00 and gave the company a “neutral” rating in a research note on Thursday. Rosenblatt Securities reissued a “sell” rating and issued a $187.00 target price (up previously from $185.00) on shares of CME Group in a research note on Thursday. Morgan Stanley raised their target price on shares of CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research note on Tuesday, April 9th. Finally, The Goldman Sachs Group downgraded shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 target price on the stock. in a research note on Wednesday, January 3rd. Two analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, CME Group presently has an average rating of “Hold” and an average target price of $217.80.

CME Group Stock Down 0.8 %

Shares of CME opened at $210.94 on Thursday. The firm has a market cap of $75.94 billion, a PE ratio of 24.00, a price-to-earnings-growth ratio of 5.97 and a beta of 0.49. The company’s fifty day moving average is $214.73 and its two-hundred day moving average is $211.90. CME Group has a fifty-two week low of $175.73 and a fifty-two week high of $223.80. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, beating analysts’ consensus estimates of $2.44 by $0.06. The company had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.48 billion. CME Group had a net margin of 56.84% and a return on equity of 12.45%. CME Group’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter last year, the business earned $2.42 EPS. Analysts forecast that CME Group will post 9.58 earnings per share for the current year.

Institutional Investors Weigh In On CME Group

Hedge funds and other institutional investors have recently modified their holdings of the stock. Gold Investment Management Ltd. bought a new stake in shares of CME Group in the 4th quarter worth about $26,000. OFI Invest Asset Management bought a new stake in shares of CME Group in the 3rd quarter worth about $25,000. Northwest Financial Advisors bought a new stake in shares of CME Group in the 4th quarter worth about $28,000. Harbor Investment Advisory LLC increased its position in shares of CME Group by 966.7% in the 4th quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock worth $34,000 after purchasing an additional 145 shares during the last quarter. Finally, BKM Wealth Management LLC acquired a new position in shares of CME Group in the 4th quarter valued at about $38,000. Institutional investors own 87.75% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.